BMS at AIBD 2020 Virtual Meeting
Phần mềm chống xóc đĩa trên điện thoại di độngHighlighting innovative research and commitment to patients in gastroenterology
Intended for U.S. scientific audiences only.
he Advances in Inflammatory Bowel Diseases (AIBD) 2020 Virtual Meeting is an important opportunity for scientific exchange with the gastroenterology research community. Our commitment to developing meaningful solutions for the community has remained steadfast in the face of unprecedented challenges over the past year, and we look forward to showcasing data that have the potential to elevate the standard of care for people living with these diseases.
Our diverse, promising pipeline is focused on innovative medicines that transform patients’ lives. Read how our scientists are addressing some of the most challenging diseases of our time, particularly in gastroenterology.
Phần mềm chống xóc đĩa trên điện thoại di độngHear from Mary Beth Harler, M.D., senior vice president and head of Immunology & Fibrosis Development, on how Bristol Myers Squibb is committed to advancing innovative science in gastroenterology.
Our research in gastroenterology spans a number of diseases and pathways of focus. Learn more below.